Cargando…
Assessment of Treatment Response after Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) for Appendiceal Peritoneal Metastases
SIMPLE SUMMARY: Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) is an emerging treatment modality for patients with peritoneal cancer with good safety profile and promising early response rates. The aim of this study was to analyze survival and surrogates for oncological response after PIPA...
Autores principales: | Somashekhar, SP, Abba, Julio, Sgarbura, Olivia, Alyami, Mohammad, Teixeira Farinha, Hugo, Rao, Ramya G., Willaert, Wouter, Hübner, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599491/ https://www.ncbi.nlm.nih.gov/pubmed/36291781 http://dx.doi.org/10.3390/cancers14204998 |
Ejemplares similares
-
Treatment Response After Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastases of Colorectal Originf
por: Hübner, Martin, et al.
Publicado: (2022) -
Selection Criteria for Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Treatment in Patients with Peritoneal Metastases
por: Balmer, Aurélie, et al.
Publicado: (2022) -
Early postoperative outcomes of staging laparoscopy for peritoneal metastases with or without pressurized intra-peritoneal aerosol chemotherapy (PIPAC)
por: Teixeira Farinha, Hugo, et al.
Publicado: (2022) -
The role of cytology in patients undergoing pressurized intraperitoneal aerosol chemotherapy (PIPAC) treatment for peritoneal carcinomatosis
por: Deban, Mélina, et al.
Publicado: (2023) -
Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) as an outpatient procedure
por: Graversen, Martin, et al.
Publicado: (2018)